Treatment Continuation Study for Patients With ALS/MND Who Completed Study CMD-2019-001

Clinical trial NCT04313166 · COMPLETED

Trial details

NCT number: NCT04313166
Sponsor: Collaborative Medicinal Development Pty Limited
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2020-03-19
Primary completion: 2021-11-18
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.